O. Mäkelä

927 total citations
21 papers, 717 citations indexed

About

O. Mäkelä is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Ecology. According to data from OpenAlex, O. Mäkelä has authored 21 papers receiving a total of 717 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Radiology, Nuclear Medicine and Imaging, 10 papers in Molecular Biology and 4 papers in Ecology. Recurrent topics in O. Mäkelä's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (4 papers) and Bacteriophages and microbial interactions (4 papers). O. Mäkelä is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Glycosylation and Glycoproteins Research (4 papers) and Bacteriophages and microbial interactions (4 papers). O. Mäkelä collaborates with scholars based in Finland, United States and Denmark. O. Mäkelä's co-authors include G. J. V. Nossal, F Péterfy, Pentti Kuusela, Christian Ehnholm, Erkki Ruoslahti, Lars R. Holsti, Carl G. Gahmberg, Timo U. Kosunen, Turgut İmir and E Saksela and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Annual Review of Microbiology.

In The Last Decade

O. Mäkelä

20 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Mäkelä Finland 13 310 268 258 51 50 21 717
Margaret Tan United States 12 200 0.6× 297 1.1× 117 0.5× 58 1.1× 70 1.4× 15 546
P Liacopoulos France 14 398 1.3× 282 1.1× 232 0.9× 63 1.2× 38 0.8× 102 789
B. Cinader Canada 14 308 1.0× 179 0.7× 126 0.5× 83 1.6× 54 1.1× 33 684
Elchanan Maron Israel 15 165 0.5× 319 1.2× 230 0.9× 28 0.5× 37 0.7× 19 559
F. R. Seiler Germany 13 216 0.7× 243 0.9× 167 0.6× 59 1.2× 90 1.8× 54 626
Carla L. McLaughlin United States 14 190 0.6× 442 1.6× 343 1.3× 120 2.4× 40 0.8× 23 730
Robert A. Nicolotti United States 8 263 0.8× 275 1.0× 235 0.9× 27 0.5× 95 1.9× 9 579
J M Decker United States 13 331 1.1× 319 1.2× 74 0.3× 56 1.1× 48 1.0× 19 632
J E Bubbers United States 15 379 1.2× 202 0.8× 156 0.6× 23 0.5× 60 1.2× 26 676
H C Kelker United States 12 289 0.9× 266 1.0× 120 0.5× 18 0.4× 47 0.9× 17 640

Countries citing papers authored by O. Mäkelä

Since Specialization
Citations

This map shows the geographic impact of O. Mäkelä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Mäkelä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Mäkelä more than expected).

Fields of papers citing papers by O. Mäkelä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Mäkelä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Mäkelä. The network helps show where O. Mäkelä may publish in the future.

Co-authorship network of co-authors of O. Mäkelä

This figure shows the co-authorship network connecting the top 25 collaborators of O. Mäkelä. A scholar is included among the top collaborators of O. Mäkelä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Mäkelä. O. Mäkelä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nossal, G. J. V. & O. Mäkelä. (1998). Genetic aspects of antibody formation.. PubMed. 10. 1094–109.
2.
Péterfy, F, Pentti Kuusela, & O. Mäkelä. (1983). Affinity requirements for antibody assays mapped by monoclonal antibodies.. The Journal of Immunology. 130(4). 1809–1813. 86 indexed citations
3.
Gahmberg, Carl G., et al.. (1979). Induction of aryl hydrocarbon hydroxylase activity and pulmonary carcinoma. International Journal of Cancer. 23(3). 302–305. 41 indexed citations
4.
Saksela, E, Turgut İmir, & O. Mäkelä. (1975). Specifically cytotoxic human and mouse lymphoid cells induced with antibody or antigen-antibody complexes.. PubMed. 115(6). 1488–92. 23 indexed citations
5.
Nakamura, Ichiro, Alex Ray, & O. Mäkelä. (1973). OLIGOMERIC IGA: THE MAJOR COMPONENT OF THE IN VITRO PRIMARY RESPONSE OF MOUSE SPLEEN FRAGMENTS. The Journal of Experimental Medicine. 138(4). 973–988. 18 indexed citations
6.
Mäkelä, O., et al.. (1971). Cell interactions and receptor antibodies in immune responses : proceedings of the third Sigrid Jusélius symposium. Academic Press eBooks. 6 indexed citations
7.
Mäkelä, O., Erkki Ruoslahti, & Christian Ehnholm. (1969). Subtypes of Human ABO Blood Groups and Subtype-Specific Antibodies. The Journal of Immunology. 102(3). 763–771. 35 indexed citations
8.
Mäkelä, O.. (1967). CELLULAR HETEROGENEITY IN THE PRODUCTION OF AN ANTI-HAPTEN ANTIBODY. The Journal of Experimental Medicine. 126(1). 159–170. 25 indexed citations
9.
Mäkelä, O.. (1965). Single Lymph Node Cells Producing Heteroclitic Bacteriophage Antibody. The Journal of Immunology. 95(2). 378–386. 53 indexed citations
10.
Mäkelä, O.. (1964). STUDIES ON THE QUALITY OF NEUTRALIZING BACTERIOPHAGE ANTIBODIES PRODUCED BY SINGLE CELLS. I. EVIDENCE INDICATING THAT DIFFERENT CELLS PRODUCE DIFFERENT KINDS OF ANTIBODY AGAINST THE TAIL OF T6.. PubMed. 7. 9–16. 10 indexed citations
11.
Mäkelä, O.. (1964). STUDIES ON THE QUALITY OF NEUTRALIZING BACTERIOPHAGE ANTIBODIES PRODUCED BY SINGLE CELLS. II. EVIDENCE INDICATING THAT DIFFERENT CELLS OF A LYMPH NODE PRODUCE DIFFERENT KINDS OF ANTIBODY AGAINST THE POLYSACCHARIDE ANTIGEN O-9,12 OF SALMONELLA.. PubMed. 7. 17–25. 5 indexed citations
12.
Nossal, G. J. V. & O. Mäkelä. (1962). AUTORADIOGRAPHIC STUDIES ON THE IMMUNE RESPONSE. The Journal of Experimental Medicine. 115(1). 209–230. 189 indexed citations
13.
Nossal, G. J. V. & O. Mäkelä. (1962). Elaboration of Antibodies by Single Cells. Annual Review of Microbiology. 16(1). 53–74. 59 indexed citations
14.
Nossal, G. J. V., et al.. (1962). Cellular proliferation in immunity.. PubMed. 20. 32–6. 3 indexed citations
15.
Mäkelä, O. & G. J. V. Nossal. (1962). Accelerated Breakdown of Immunological Tolerance Following Whole Body Irradiation. The Journal of Immunology. 88(5). 613–620. 29 indexed citations
16.
Nossal, G. J. V. & O. Mäkelä. (1962). Kinetic Studies on the Incidence of Cells Appearing to form Two Antibodies. The Journal of Immunology. 88(5). 604–612. 37 indexed citations
17.
Mäkelä, O. & G. J. V. Nossal. (1961). Bacterial Adherence: A Method for Detecting Antibody Production by Single Cells. The Journal of Immunology. 87(4). 447–456. 68 indexed citations
18.
Mäkelä, O., et al.. (1961). STUDIES ON THE TRANSFER OF NUCLEOPROTEIN FRACTIONS FROM IMMUNIZED SPLEENS. Plastic & Reconstructive Surgery. 28(6). 478–478. 2 indexed citations
19.
Mäkelä, O., Kari Cantell, & K Penttinen. (1959). Failure of Mumps Virus to Inactivate Agglutinogens M, N and Rho (D) of Human Red Cells. The Journal of Immunology. 83(2). 127–132. 5 indexed citations
20.
Mäkelä, O. & Petra Mäkelä. (1956). Some new blood group specific phytagglutinins; a preliminary report.. PubMed. 34(4). 402–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026